KRTX
T. Rowe Price Associates’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,961,587
| Closed | -$621M | – | 2991 |
|
|
2023
Q4 | $621M | Sell |
1,961,587
-773,251
| -28% | -$245M | 0.08% | 224 |
|
|
2023
Q3 | $462M | Buy |
2,734,838
+73,346
| +3% | +$12.4M | 0.07% | 247 |
|
|
2023
Q2 | $577M | Buy |
2,661,492
+179,932
| +7% | +$39M | 0.08% | 229 |
|
|
2023
Q1 | $451M | Buy |
2,481,560
+118,256
| +5% | +$21.5M | 0.07% | 255 |
|
|
2022
Q4 | $464M | Buy |
2,363,304
+147,158
| +7% | +$28.9M | 0.07% | 243 |
|
|
2022
Q3 | $498M | Buy |
2,216,146
+191,307
| +9% | +$43M | 0.08% | 227 |
|
|
2022
Q2 | $256M | Sell |
2,024,839
-86,395
| -4% | -$10.9M | 0.03% | 413 |
|
|
2022
Q1 | $268M | Buy |
2,111,234
+155,868
| +8% | +$19.8M | 0.03% | 453 |
|
|
2021
Q4 | $256M | Buy |
1,955,366
+114,735
| +6% | +$15M | 0.02% | 490 |
|
|
2021
Q3 | $225M | Buy |
1,840,631
+57,363
| +3% | +$7.02M | 0.02% | 513 |
|
|
2021
Q2 | $203M | Buy |
1,783,268
+92,493
| +5% | +$10.5M | 0.02% | 552 |
|
|
2021
Q1 | $203M | Buy |
1,690,775
+266,614
| +19% | +$32.1M | 0.02% | 547 |
|
|
2020
Q4 | $145M | Buy |
1,424,161
+49,073
| +4% | +$4.99M | 0.01% | 608 |
|
|
2020
Q3 | $106M | Buy |
1,375,088
+8,478
| +0.6% | +$656K | 0.01% | 638 |
|
|
2020
Q2 | $152M | Sell |
1,366,610
-453,333
| -25% | -$50.5M | 0.02% | 530 |
|
|
2020
Q1 | $131M | Buy |
1,819,943
+1,088,336
| +149% | +$78.4M | 0.02% | 506 |
|
|
2019
Q4 | $55.1M | Buy |
731,607
+273,626
| +60% | +$20.6M | 0.01% | 884 |
|
|
2019
Q3 | $7.47M | Buy |
457,981
+4,607
| +1% | +$75.2K | ﹤0.01% | 1326 |
|
|
2019
Q2 | $9.08M | Buy |
+453,374
| New | +$9.08M | ﹤0.01% | 1325 |
|